KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 3 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,500 | -31.6% | 73,922 | -12.3% | 0.01% | -33.3% |
Q2 2023 | $18,283 | +115.5% | 84,316 | +80.5% | 0.01% | +200.0% |
Q1 2023 | $8,484 | +46.6% | 46,709 | +58.6% | 0.00% | +33.3% |
Q4 2022 | $5,786 | -99.9% | 29,445 | -5.3% | 0.00% | -62.5% |
Q3 2022 | $6,994,000 | +2185.6% | 31,098 | +1187.2% | 0.01% | – |
Q2 2022 | $306,000 | -75.6% | 2,416 | -75.6% | 0.00% | -100.0% |
Q1 2022 | $1,256,000 | -88.2% | 9,909 | -87.8% | 0.00% | -50.0% |
Q4 2021 | $10,618,000 | +357.9% | 81,056 | +327.7% | 0.00% | +100.0% |
Q3 2021 | $2,319,000 | +17.0% | 18,953 | +9.1% | 0.00% | 0.0% |
Q2 2021 | $1,982,000 | -45.6% | 17,373 | -42.7% | 0.00% | -50.0% |
Q1 2021 | $3,642,000 | -12.0% | 30,303 | -25.6% | 0.00% | 0.0% |
Q4 2020 | $4,137,000 | +549.5% | 40,723 | +393.8% | 0.00% | – |
Q3 2020 | $637,000 | -38.5% | 8,247 | -11.3% | 0.00% | -100.0% |
Q2 2020 | $1,035,000 | +277.7% | 9,295 | +144.7% | 0.00% | – |
Q1 2020 | $274,000 | -29.2% | 3,799 | -26.0% | 0.00% | – |
Q4 2019 | $387,000 | +945.9% | 5,137 | +127.5% | 0.00% | – |
Q3 2019 | $37,000 | – | 2,258 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |